STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZTS
  4. [Form 4] Zoetis Inc. Insider Trading Activity

Zoetis (ZTS) director Frank D'Amelio buys 6,650 shares in open market

Filing Impact
(High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Zoetis Inc. director Frank A. D'Amelio bought shares of the company in the open market. He purchased 6,650 shares of Zoetis common stock at a price of $75.39 per share in a single transaction. Following this purchase, he directly owns 21,458 shares of Zoetis common stock.

Positive

  • None.

Negative

  • None.
Insider DAMELIO FRANK A
Role null
Bought 6,650 shs ($501K)
Type Security Shares Price Value
Purchase Common Stock 6,650 $75.39 $501K
Holdings After Transaction: Common Stock — 21,458 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares purchased 6,650 shares Open-market purchase of Zoetis common stock
Purchase price $75.39 per share Price for single transaction on common stock
Post-transaction holdings 21,458 shares Total direct Zoetis common shares owned after purchase
Net buy shares 6,650 shares Net change in buy/sell activity in this Form 4
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open-market purchase financial
"transaction_action: "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
direct ownership financial
"ownership_type: "direct" and direct_or_indirect: "D""
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DAMELIO FRANK A
(Last)(First)(Middle)
C/O ZOETIS INC.
10 SYLVAN WAY
(Street)
PARSIPPANY NEW JERSEY 07054
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/13/2026P6,650A$75.39(1)21,458D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The Price reported in Table I, Column 4 is the price at which these shares were purchased in a single transaction.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Zoetis (ZTS) director Frank A. D'Amelio report?

Frank A. D'Amelio reported an open-market purchase of Zoetis common stock. He bought 6,650 shares in a single transaction, indicating he increased his personal stake in the company’s equity through a direct ownership position.

At what price did the Zoetis (ZTS) director buy his shares?

He bought the shares at $75.39 per share. The filing notes this was the price for a single purchase transaction, providing clear detail on the cost basis of this insider acquisition of Zoetis common stock.

How many Zoetis (ZTS) shares does Frank A. D'Amelio own after this transaction?

After the reported transaction, Frank A. D'Amelio directly owns 21,458 shares of Zoetis common stock. This figure represents his total direct holdings as disclosed in the Form 4 following the 6,650-share open-market purchase.

Was the Zoetis (ZTS) insider transaction a purchase or a sale?

The transaction was a purchase. The Form 4 identifies the code as “P,” describing an open-market or private transaction purchase of 6,650 Zoetis common shares by director Frank A. D'Amelio, increasing his directly held position.

Does the Zoetis (ZTS) insider hold these shares directly or indirectly?

He holds these Zoetis shares directly. The Form 4 classifies the ownership type as direct, meaning the 21,458 post-transaction shares are owned by Frank A. D'Amelio himself rather than through an intermediary entity or trust.